|
GTX01511
|
GeneTex International Corporation
|
UEA I Lectin (Biotin)
|
Human
|
ELISA, IHC, WB
|
|
|
HY-100490A-10mg
|
MedChemexpress LLC
|
Rilmenidine (hemifumarate) [CAS 207572-68-7]
|
|
Cancer-programmed cell death
|
|
|
HY-100490A-100mg
|
MedChemexpress LLC
|
Rilmenidine (hemifumarate) [CAS 207572-68-7]
|
|
Cancer-programmed cell death
|
|
|
HY-100490A-25mg
|
MedChemexpress LLC
|
Rilmenidine (hemifumarate) [CAS 207572-68-7]
|
|
Cancer-programmed cell death
|
|
|
HY-100490A-5mg
|
MedChemexpress LLC
|
Rilmenidine (hemifumarate) [CAS 207572-68-7]
|
|
Cancer-programmed cell death
|
|
|
HY-100490A-50mg
|
MedChemexpress LLC
|
Rilmenidine (hemifumarate) [CAS 207572-68-7]
|
|
Cancer-programmed cell death
|
|
|
HY-100490B-10mg
|
MedChemexpress LLC
|
Rilmenidine (phosphate) [CAS 85409-38-7]
|
|
Cancer-programmed cell death
|
|
|
HY-100490B-100mg
|
MedChemexpress LLC
|
Rilmenidine (phosphate) [CAS 85409-38-7]
|
|
Cancer-programmed cell death
|
|
|
HY-100490B-25mg
|
MedChemexpress LLC
|
Rilmenidine (phosphate) [CAS 85409-38-7]
|
|
Cancer-programmed cell death
|
|
|
HY-100490B-5mg
|
MedChemexpress LLC
|
Rilmenidine (phosphate) [CAS 85409-38-7]
|
|
Cancer-programmed cell death
|
|
|
HY-100490B-50mg
|
MedChemexpress LLC
|
Rilmenidine (phosphate) [CAS 85409-38-7]
|
|
Cancer-programmed cell death
|
|
|
HY-100678-10mg
|
MedChemexpress LLC
|
CGS 15943 [CAS 104615-18-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-100678-25mg
|
MedChemexpress LLC
|
CGS 15943 [CAS 104615-18-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-100678-5mg
|
MedChemexpress LLC
|
CGS 15943 [CAS 104615-18-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-10095-10mg
|
MedChemexpress LLC
|
Olcegepant [CAS 204697-65-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-10095-2mg
|
MedChemexpress LLC
|
Olcegepant [CAS 204697-65-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-10095-25mg
|
MedChemexpress LLC
|
Olcegepant [CAS 204697-65-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-10095-5mg
|
MedChemexpress LLC
|
Olcegepant [CAS 204697-65-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-10095-50mg
|
MedChemexpress LLC
|
Olcegepant [CAS 204697-65-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-10095A-10mg
|
MedChemexpress LLC
|
Olcegepant (hydrochloride) [CAS 586368-06-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-10095A-100mg
|
MedChemexpress LLC
|
Olcegepant (hydrochloride) [CAS 586368-06-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-10095A-5mg
|
MedChemexpress LLC
|
Olcegepant (hydrochloride) [CAS 586368-06-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-10095A-50mg
|
MedChemexpress LLC
|
Olcegepant (hydrochloride) [CAS 586368-06-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101370-1mg
|
MedChemexpress LLC
|
2-Methylthio-ATP (tetrasodium) [CAS 100020-57-3]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-101422-10mg
|
MedChemexpress LLC
|
GAL-021 [CAS 1380341-99-0]
|
|
COVID-19-immunoregulation
|
|
